Recent advances in bionanomaterials for liver cancer diagnosis and treatment

被引：30

作者：

Chowdhury, Mohammed Mehadi Hassan ^{[1
,2
]}

Salazar, Christiancel Joseph J. ^{[3
]}

Nurunnabi, Md ^{[3
,4
,5
,6
]}

机构：

[1] Deakin Univ, Fac Hlth, Sch Med, 75 Pigdons Rd, Waurnponds, Vic 3216, Australia

[2] Noakhali Sci & Technol Univ, Dept Microbiol, Noakhali 3814, Bangladesh

[3] Univ Texas El Paso, Environm Sci & Engn, El Paso, TX 79968 USA

[4] Univ Texas El Paso, Biomed Engn, El Paso, TX 79968 USA

[5] Univ Texas El Paso, Sch Pharm, Dept Pharmaceut Sci, El Paso, TX 79902 USA

[6] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA

来源：

BIOMATERIALS SCIENCE | 2021年 / 9卷 / 14期

关键词：

MESOPOROUS SILICA NANOPARTICLES; IRON-OXIDE NANOPARTICLES; HEPATOCELLULAR-CARCINOMA; CO-DELIVERY; IN-VITRO; ARSENIC TRIOXIDE; PHOTOTHERMAL THERAPY; GOLD NANOPARTICLES; TARGETED DELIVERY; DRUG-DELIVERY;

D O I：

10.1039/d1bm00167a

中图分类号：

TB3 [工程材料学]; R318.08 [生物材料学];

学科分类号：

0805 ; 080501 ; 080502 ;

摘要：

According to the World Health Organization, liver cancer is the fourth leading cause of cancer associated with death worldwide. It demands effective treatment and diagnostic strategies to hinder its recurrence, complexities, aggressive metastasis and late diagnosis. With recent progress in nanotechnology, several nanoparticle-based diagnostic and therapeutic modalities have entered into clinical trials. With further developments in nanoparticle mediated liver cancer diagnosis and treatment, the approach holds promise for improved clinical liver cancer management. In this review, we discuss the key advances in nanoparticles that have potential for liver cancer diagnosis and treatment. We also discuss the potential of nanoparticles to overcome the limitations of existing therapeutic modalities.

引用

页码：4821 / 4842

页数：22

共 231 条

[1] A Comparative Evaluation of the Antiproliferative Activity against HepG2 Liver Carcinoma Cells of Plant-Derived Silver Nanoparticles from Basil Extracts with Contrasting Anthocyanin Contents
Abbasi, Bilal Haider
Nazir, Munazza
Muhammad, Wali
Hashmi, Syed Salman
Abbasi, Rashda
Rahman, Lubna
Hano, Christophe
[J]. BIOMOLECULES, 2019, 9 (08)
[2] Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells
Abu-Serie, Marwa M.
[J]. SCIENTIFIC REPORTS, 2018, 8
[3] Efficiency of novel nanocombinations of bovine milk proteins (lactoperoxidase and lactoferrin) for combating different human cancer cell lines
Abu-Serie, Marwa M.
El-Fakharany, Esmail M.
[J]. SCIENTIFIC REPORTS, 2017, 7
[4] Near infrared-emitting persistent luminescent nanoparticles for Hepatocellular Carcinoma imaging and luminescence-guided surgery
Ai, Ting
Shang, Wenting
Yan, Hao
Zeng, Chaoting
Wang, Kun
Gao, Yuan
Guan, Tianpei
Fang, Chihua
Tian, Jie
[J]. BIOMATERIALS, 2018, 167 : 216 - 225
[5] Al-Hrout A, 2017, BIOTECHNOLOGY AND PRODUCTION OF ANTI-CANCER COMPOUNDS, P73, DOI 10.1007/978-3-319-53880-8_3
[6] Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy
Al-Shakarchi, Wejdan
Alsuraifi, Ali
Abed, Mohammed
Abdullah, Marwan
Richardson, Alan
Curtis, Anthony
Hoskins, Clare
[J]. PHARMACEUTICS, 2018, 10 (02):
[7] Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
[8] Silver-doped graphene oxide nanocomposite triggers cytotoxicity and apoptosis in human hepatic normal and carcinoma cells
Ali, Daoud
Alarifi, Saud
Alkahtani, Saad
Almeer, Rafa S.
[J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 5685 - 5699
[9] Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells
Anirudhan, Thayyath Sreenivasan
Binusreejayan
[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 88 : 222 - 235
[10] Nanoparticles in the clinic: An update
Anselmo, Aaron C.
Mitragotri, Samir
[J]. BIOENGINEERING & TRANSLATIONAL MEDICINE, 2019, 4 (03)

← 1 2 3 4 5 6 7 8 9 10 →